Skip to main content
. 2022 Mar 8;12(3):e055596. doi: 10.1136/bmjopen-2021-055596

Table 2.

Sample sizes for a test-negative case-control study design, assuming 80% power to detect an OR=1-VE, by per cent coverage among controls (those testing negative) and number of controls per case, with a two-sided alpha=0.05 test.

Vaccine efficacy (VE; %) Coverage (% vaccinated among controls) Sample size (no. of cases) by number of controls per case
1 2 3 4
90 5 210 171 157 149
10 103 84 77 73
20 50 40 37 35
30 32 26 23 22
50 19 15 13 12
70 14 11 9 9
70 5 418 333 303 288
10 211 167 152 144
20 107 84 76 72
30 74 57 52 49
50 50 38 34 32
70 46 34 30 28
50 5 962 749 677 641
10 492 383 345 326
20 260 201 181 171
30 186 143 128 120
50 137 103 92 86
70 141 105 92 86
30 5 3070 2350 2109 1989
10 1593 1218 1092 1029
20 866 659 590 555
30 638 483 432 406
50 499 375 334 313
70 553 412 364 340